论文部分内容阅读
目的:针对痉挛型脑性瘫痪儿童,讨论肌电生物反馈法在儿童康复中的疗效,为日后的临床治疗提供参考与指导。方法:选择我院于2013年2月-2015年5月收治的痉挛型脑性瘫痪儿童120例为研究对象,应用抽签的方法,将120例患儿随机划分为两组,分别命名为观察组及对照组,每组患儿60例。观察组患儿给予肌电生物反馈疗法,对照组患儿给予痉挛肌治疗。对比两组患儿的腓肠肌痉挛评分(MAS)。结果:在临床治疗前,观察组患儿的MAS评分为3.48±0.46分,对照组为3.51±0.47分,两组比较不显著,差异无统计学意义,P>0.05。临床治疗后,观察组患儿的MAS评分为2.65±0.59分,对照组为2.89±0.90分,两组比较显著,差异有统计学意义,P<0.05,观察组优于对照组。结论:痉挛型脑性瘫痪是一种难以治愈的疾病,多数儿童的生活质量较低。针对患儿实施肌电生物反馈疗法后,可帮助患儿取得较好的康复效果,减少并发症,提高患儿的生活质量。建议在今后的临床治疗中,将肌电生物反馈疗法推广应用。
Objective: To investigate the efficacy of myoelectricity biofeedback in children with spastic cerebral palsy and to provide reference and guidance for future clinical treatment. Methods: A total of 120 children with spastic cerebral palsy who were treated in our hospital from February 2013 to May 2015 were selected as the research objects. 120 children were randomly divided into two groups according to the method of lottery. They were named as observation group And control group, 60 cases in each group. The observation group was given electromyogram biofeedback therapy and the control group was given spastic muscle treatment. Gastrocnemius muscle spasm scores (MAS) were compared between the two groups. Results: Before clinical treatment, the score of MAS in observation group was 3.48 ± 0.46 and in control group was 3.51 ± 0.47. There was no significant difference between the two groups (P> 0.05). After clinical treatment, the MAS score of the observation group was 2.65 ± 0.59 and the control group was 2.89 ± 0.90, the difference was statistically significant (P <0.05). The observation group was superior to the control group. Conclusion: Spastic cerebral palsy is a difficult to cure disease, and most children have a lower quality of life. The implementation of myoelectric biofeedback therapy for children can help children get better rehabilitation results, reduce complications and improve children’s quality of life. Proposed in the future clinical treatment, the myoelectric biofeedback therapy to promote the application.